Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Zepbound (Tirzepatide) Zepbound, another injectable medication, targets both GLP-1 and GIP hormones to further enhance weight loss outcomes
Side effects: Similarities and potential differences Weight loss patches currently available are not GLP-1 mimetics, and may not have the same side effects as GLP-1 drugs, like Wegovy, Ozempic, Mounjaro, or Zepbound
This medicalization of obesity, along with aggressive pharmaceutical marketing, raises ethical questions about commercial influences on prescribing practices
Your body needs time to adjust to both the medication and your new body weight
Research tracks around 6% drop by week 12 and 12% by week 28